As several cancer therapies are associated with increased MVP expression, our results reaffirm the role of MVP in drug resistance and we wonder whether these MVP-mediated mechanisms may be generally involved in resistance to new inhibitors against other Ras mutants29–31 and perhaps other cancer drugs. This evidence concerns the gene MVP and cancer.